# Jorge Plutzky

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jorge-plutzky/

## Facts

| Field | Value |
| --- | --- |
| Citations | 27,940 |
| Field | Lipoproteins and Cardiovascular Health |
| h-index | 79 |
| i10-index | 175 |
| Last Known Institution | Brigham and Women's Hospital |
| OpenAlex ID | https://openalex.org/A5051351787 |
| ORCID iD | https://orcid.org/0000-0002-7194-9876 |
| Works | 317 |

## Researcher papers

- [Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes](https://scholariq.org/papers/semaglutide-and-cardiovascular-outcomes-in-obesity-without-diabetes/)
- [Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus](https://scholariq.org/papers/primary-prevention-of-cardiovascular-diseases-in-people-with-diabetes-mellitus-2/)
- [Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients](https://scholariq.org/papers/bempedoic-acid-and-cardiovascular-outcomes-in-statin-intolerant-patients/)
- [Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus](https://scholariq.org/papers/primary-prevention-of-cardiovascular-diseases-in-people-with-diabetes-mellitus/)
- [The Residual Risk Reduction Initiative: A Call to Action to Reduce Residual Vascular Risk in Patients with Dyslipidemia](https://scholariq.org/papers/the-residual-risk-reduction-initiative-a-call-to-action-to-reduce-residual/)
- [Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial](https://scholariq.org/papers/long-term-weight-loss-effects-of-semaglutide-in-obesity-without-diabetes-in-the/)
- [Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial](https://scholariq.org/papers/long-term-kidney-outcomes-of-semaglutide-in-obesity-and-cardiovascular-disease/)

## Researcher topics

- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Peroxisome Proliferator-Activated Receptors](https://scholariq.org/topics/peroxisome-proliferator-activated-receptors/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)

## Researcher university

- [Brigham and Women's Hospital](https://scholariq.org/institutions/brigham-and-women-s-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.